News articles about Cognex (NASDAQ:CGNX) have trended somewhat positive on Wednesday, Accern reports. Accern ranks the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cognex earned a daily sentiment score of 0.14 on Accern’s scale. Accern also gave media coverage about the scientific and technical instruments company an impact score of 46.9025989003031 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.
These are some of the news headlines that may have effected Accern Sentiment’s analysis:
- Is The Stock Highly Volatile? – Cognex Corporation, (NASDAQ: CGNX) – Stock Watch (stocksnewstimes.com)
- Traders Alert: Adecoagro SA (NYSE:AGRO), Cognex Corporation (NASDAQ:CGNX) – The Oracle Examiner (oracleexaminer.com)
- Insider Selling: Cognex Co. (CGNX) Director Sells 10,000 Shares of Stock (americanbankingnews.com)
- Movers of most recent trading session: Cognex Corporation (NASDAQ:CGNX), Louisiana-Pacific Corp. (NYSE:LPX) – The Oracle Examiner (oracleexaminer.com)
- Cognex Corporation (CGNX) – Analyst rating score stands at 2.50 – Nasdaq Fortune (press release) (nasdaqfortune.com)
CGNX has been the subject of a number of recent research reports. BidaskClub downgraded shares of Cognex from a “buy” rating to a “hold” rating in a research note on Thursday, December 7th. ValuEngine downgraded shares of Cognex from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. Zacks Investment Research downgraded shares of Cognex from a “strong-buy” rating to a “sell” rating in a research note on Tuesday, January 2nd. Finally, Deutsche Bank set a $80.00 target price on shares of Cognex and gave the company a “buy” rating in a research note on Friday, January 19th. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the stock. Cognex presently has an average rating of “Hold” and a consensus price target of $66.83.
Cognex (NASDAQ:CGNX) last issued its quarterly earnings data on Thursday, February 15th. The scientific and technical instruments company reported $0.30 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.25 by $0.05. Cognex had a net margin of 23.69% and a return on equity of 24.23%. The company had revenue of $180.37 million during the quarter, compared to the consensus estimate of $178.75 million. During the same quarter in the prior year, the firm earned $0.20 earnings per share. The firm’s revenue was up 39.5% compared to the same quarter last year. equities research analysts predict that Cognex will post 1.4 earnings per share for the current year.
Cognex announced that its Board of Directors has initiated a stock buyback program on Thursday, February 15th that authorizes the company to buyback $150.00 million in shares. This buyback authorization authorizes the scientific and technical instruments company to buy shares of its stock through open market purchases. Shares buyback programs are usually a sign that the company’s leadership believes its shares are undervalued.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 16th. Stockholders of record on Friday, March 2nd will be given a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a dividend yield of 0.33%. The ex-dividend date is Thursday, March 1st. Cognex’s dividend payout ratio is 18.37%.
In other news, Director Anthony Sun sold 10,000 shares of the stock in a transaction on Monday, March 12th. The shares were sold at an average price of $56.49, for a total transaction of $564,900.00. Following the completion of the sale, the director now owns 294,262 shares of the company’s stock, valued at $16,622,860.38. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 5.60% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect Cognex (NASDAQ:CGNX) Stock Price” was first reported by BBNS and is owned by of BBNS. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The legal version of this story can be read at https://baseballnewssource.com/2018/03/14/cognex-cgnx-earning-somewhat-favorable-media-coverage-study-finds/1927260.html.
Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.